News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cardiac Science Inc. (CSCX) Gains Japanese Regulatory Approval for Powerheart AED


7/8/2011 6:29:25 AM

BOTHELL, Wash., July 8, 2011 /PRNewswire/ -- Cardiac Science Corporation, a global leader in automated external defibrillators (AEDs) and diagnostic cardiac monitoring devices, announced today that the Japan Ministry of Health, Labor, and Welfare approved a new model of its Powerheart® G3 AED. The company is partnering with Omron Healthcare to distribute its AEDs in Japan. Japan-based Omron is a leading healthcare company dedicated to prevention of heart disease.

(Logo: http://photos.prnewswire.com/prnh/20080306/AQTH510LOGO)

(Logo: http://photos.prnewswire.com/prnh/20110708/LA31990LOGO)

"We are proud to partner with Omron to distribute our Powerheart AED in Japan," said Dave Marver, Chief Executive Officer, Cardiac Science Corporation. "They are a highly reputable company with an impressive sales and service capability. We were once AED market leaders in Japan and we look forward to reclaiming that status with Omron as our trusted partner."

Japan is the second largest AED market in the world with 65,000 AEDs sold annually. Cardiac Science and Omron Healthcare are currently engaged in market launch preparations, with commercial release and first revenue sales expected in August, 2011.

About Cardiac Science

Cardiac Science, an Opto Circuits (India) Ltd. company, develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, PC-based diagnostic workstations, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton® brands, is headquartered in Bothell, Washington. With customers in almost 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

LOGO: http://www.cardiacscience.com/images/main_logo.gif

For updates and information on worldwide defibrillation and cardiac monitoring, find us on the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, Facebook at http://budurl.com/CSonFB, and YouTube at http://budurl.com/CSonYT.

About Omron Healthcare

Omron Healthcare Co. Ltd. is based out of Kyoto, Japan. Omron Healthcare Group is a market leader in blood pressure monitoring with over 100 million of its monitors sold worldwide to date. Omron Healthcare is committed to offering clinically proven, innovative weight management, thermometry products and devices for use in treatment of respiratory conditions, as well as medical devices for hospitals, clinics, and physician's offices. In addition to those products and devices, Omron Healthcare offers a Web-based service which is designed to provide a health self-monitoring system and professional advice with the aim of helping people improve their quality of life.

For more information, contact (media) amironova@cardiacscience.com +1.425.402.2092 | (investors) ir@optoindia.com | +91.80.2852.8088

SOURCE Cardiac Science Corporation


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES